IPA to Present at The Microcap Conference 2025
-
SFWJ / Medcana Announces Strategic Expansion Into Australia With Acquisition of Cannabis Import and Distribution Licenses
-
Arsenal's Havertz could return for Champions League final
-
US officials split on Ukraine truce prospects
-
Client brain-dead after Paris cryotherapy session goes wrong
-
Flick demands answers from La Liga for 'joke' schedule
-
'Maddest game' sums up Man Utd career for Maguire
-
Trial opens for students, journalists over Istanbul protests
-
Gaza rescuers say Israeli strikes kill 24 after Hamas rejects truce proposal
-
'Really stuck': Ukraine's EU accession drive stumbles
-
'Not the time to discuss future', says Alonso amid Real Madrid links
-
74 killed in deadliest US attack on Yemen, Huthis say
-
Southgate's ex-assistant Holland fired by Japan's Yokohama
-
Vance meets Meloni in Rome before Easter at the Vatican
-
Ryan Gosling to star in new 'Star Wars' film
-
Hamas calls for pressure to end Israel's aid block on Gaza
-
Russia says Ukraine energy truce over, US mulls peace talks exit
-
58 killed in deadliest US strike on Yemen, Huthis say
-
Museums rethink how the Holocaust should be shown
-
Three dead after deadly spring storm wreaks havoc in the Alps
-
No need for big changes at Liverpool, says Slot
-
Bloody Philippine passion play sees final performance of veteran 'Jesus'
-
New US envoy prays, delivers Trump 'peace' message at Western Wall
-
Postecoglou sticking around 'a little longer' as Spurs show fight in Frankfurt
-
US threatens to withdraw from Ukraine talks if no progress
-
Tears and defiance in Sumy as Russia batters Ukraine border city
-
Russia rains missiles on Ukraine as US mulls ending truce efforts
-
Tokyo leads gains in most Asian markets on trade deal hopes
-
Two missing after deadly spring snowstorm wreaks havoc in the Alps
-
'War has taken everything': AFP reporter returns home to Khartoum
-
US strikes on Yemen fuel port kill 38, Huthis say
-
Slegers targets Lyon scalp in pursuit of Arsenal European glory
-
'Defend ourselves': Refugee girls in Kenya find strength in taekwondo
-
China's manufacturing backbone feels Trump trade war pinch
-
Sri Lankans throng to Kandy for rare display of Buddhist relic
-
Chinese vent anger at Trump's trade war with memes, mockery
-
Heartbroken Brits abandon pets as living costs bite
-
Mongolian LGBTQ youth fight for recognition through music, comedy
-
Cash crunch leaves Syrians queueing for hours to collect salaries
-
Lyon left to regroup for Champions League bid after painful European exit
-
Unravelling Real Madrid face Athletic Bilbao Liga test
-
Napoli disturbing buoyant Inter's peace in Serie A Easter bonanza
-
Disappointed Dortmund chase consistency with Europe at stake
-
Asian markets mixed as traders track tariff talks
-
Yan and Buhai share lead at LA Championship
-
Under fire at debate, Canada PM Carney tries to focus on Trump
-
Liverpool poised for Premier League coronation, Leicester, Ipswich for relegation
-
India's elephant warning system tackles deadly conflict
-
US senator meets wrongfully deported Salvadoran migrant
-
Gustavo Dudamel: the superstar conductor building bridges to pop
-
Japan rice prices soar as core inflation accelerates
IPA to Present at The Microcap Conference 2025
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, today announced is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, in Atlantic City, NJ.
IPA's management team will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company's recent developments, growth strategy, and investment opportunities.
About The Microcap Conference 2025
The Microcap Conference is the largest independent microcap event in the U.S., bringing together top-tier investors and executives from microcap companies. The event offers a platform for companies to showcase their value propositions through presentations, one-on-one meetings, and networking opportunities.
The 2025 event will feature:
Keynote Speakers: Renowned industry figures, including Jon Ledecky, Co-Owner of the New York Islanders, who will engage in a fireside chat with CNBC's Bob Pisani; plus Tom Gardner, CEO of Motley Fool, who will share insights on investing, market trends, and entrepreneurial success.
Expert Panels and Presentations: Financial commentators Ron Insana (CNBC) and Charlie Gasparino (FOX Business) will cover critical topics for the US equity markets, from capital formation to regulatory updates and market trends.
Entertainment Headliner: A special performance by Tom Papa, celebrated comedian and host of Netflix specials, ensuring a memorable evening for attendees.
Hosted by DealFlow Events, The Microcap Conference is renowned for its blend of high-quality content, engaging networking, and exceptional entertainment. For more information, visit https://themicrocapconference.com.
About ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and is known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe including entities such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the "IPA Family").
Investor Relations Contact
SOURCE: ImmunoPrecise Antibodies Ltd.
P.Mathewson--AMWN
